Your browser doesn't support javascript.
loading
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.
Seow, Jeffrey; Graham, Carl; Hallett, Sadie R; Lechmere, Thomas; Maguire, Thomas J A; Huettner, Isabella; Cox, Daniel; Khan, Hataf; Pickering, Suzanne; Roberts, Rebekah; Waters, Anele; Ward, Christopher C; Mant, Christine; Pitcher, Michael J; Spencer, Jo; Fox, Julie; Malim, Michael H; Doores, Katie J.
Afiliação
  • Seow J; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Graham C; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Hallett SR; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Lechmere T; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Maguire TJA; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Huettner I; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Cox D; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Khan H; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Pickering S; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Roberts R; Harrison Wing, Guy's and St Thomas' NHS Trust, London, UK.
  • Waters A; Harrison Wing, Guy's and St Thomas' NHS Trust, London, UK.
  • Ward CC; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Mant C; Infectious Diseases Biobank, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Pitcher MJ; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Spencer J; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Fox J; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK; Harrison Wing, Guy's and St Thomas' NHS Trust, London, UK.
  • Malim MH; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Doores KJ; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Electronic address: katie.doores@kcl.ac.uk.
Cell Rep ; 39(5): 110757, 2022 05 03.
Article em En | MEDLINE | ID: mdl-35477023
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido